Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Barquín, Aránzazu
8  Ergebnisse:
Personensuche X
?
1

Rucaparib for PARP inhibitor-pretreated ovarian cancer: A G..:

Yubero, Alfonso ; Estévez, Purificación ; Barquín, Aránzazu...
Gynecologic Oncology Reports.  48 (2023)  - p. 101211 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Rucaparib in recurrent ovarian cancer: real-world experienc..:

Yubero, Alfonso ; Barquín, Aranzazu ; Estévez, Purificación...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
3

Rucaparib for PARP inhibitor-pretreated ovarian cancer: A G..:

Yubero, Alfonso ; Estévez, Purificación ; Barquín, Aránzazu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314222/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Rucaparib in recurrent ovarian cancer: real-world experienc..:

Yubero, Alfonso ; Barquín, Aranzazu ; Estévez, Purificación...
http://hdl.handle.net/10668/20283.  , 2022
Link: http://hdl.handle.net/10..
 
?
5

Rucaparib in recurrent ovarian cancer: real-world experienc..:

Yubero, Alfonso ; Barquín, Aranzazu ; Estévez, Purificación...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644462/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Rucaparib for PARP inhibitor-pretreated ovarian cancer: A G..:

Alfonso Yubero ; Purificación Estévez ; Aránzazu Barquín...
http://www.sciencedirect.com/science/article/pii/S2352578923000802.  , 2023
Link: https://doi.org/10.1016/..
 
?
7

Rucaparib in recurrent ovarian cancer: real-world experienc..:

Alfonso Yubero ; Aranzazu Barquín ; Purificación Estévez...
https://doi.org/10.1186/s12885-022-10191-5.  , 2022
Link: https://doi.org/10.1186/..
 
?
8

Prognostic value of quantitative ctDNA levels in non small ..:

Provencio, Mariano ; Torrente, María ; Calvo, Virginia...
Oncotarget.  9 (2017)  1 - p. 488-494 , 2017
Link: https://doi.org/10.18632..
 
1-8